Since the discovery of the genetic basis for cystic fibrosis in 1989, scientists have developed a variety of viral and
non-viral vector systems for delivering a corrected CFTR gene back into lung cells.
Not exact matches
In January 2008, he started his own group in ISCR and succeeded in making a
non-viral single
vector reprogramming
system, which has been applied to both mouse and human cells using the piggyBac transposon in collaboration with Prof. Andras Nagy in Toronto (Kaji, et al., Nature, 2009, Woltjen, et al., Nature, 2009).
Viral
vectors have the main adverse effect of inducing neutralizing antibodies, while several
non-viral vectors present toxic effects (e.g. respiratory
system).14, 15 In an effort to deliver efficiently the necessary drug concentration to the tumor site and prevent systemic adverse effects, the concept of administering local treatment for lung cancer has been explored.